I would like to receive updates and special offers from Dow Jones and affiliates. I can unsubscribe at any time.

American Uranium's direct exposure to low-cost US domestic uranium supply has earned it a bullish 12-month target price of ...

Monday, September 29, 2025The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 12 major stocks, including Wells Fargo ...

YES Bank shares are up following Sumitomo Mitsui Banking Corporation's increased stake. This move boosts investor confidence ...

CHENNAI: India's largest drug maker Sun Pharmaceutical Industries may face a comparatively bigger challenge in the US market ...

Artificial intelligence chip heavyweight Nvidia could have more competition to contend with after Broadcom's strong quarterly ...

In a board meeting last week, the company approved a preferential allotment of 18,05,55,555 equity shares and 9,72,22,222 ...

A year ago, the maker of Tylenol lauded a federal judge’s dismissal of hundreds of lawsuits alleging the popular painkiller ...

The new framework comes amid frail times for rare disease drug research in the US. The US Food and Drug Administration (FDA) has created a new pathway to streamline rare disease drugs through ...

Big names such as Singtel and DBS are among the eight companies identified as potential beneficiaries Read more at The Business Times.

The Bank of Punjab (BOP) yesterday hosted a corporate briefing for brokerages, research analysts, and market participants to ...

Celestica Inc. (TSX and NYSE: CLS) will hold its third quarter 2025 financial results conference call and 2025 Investor and ...